We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AdvaMed Tells FDA That Draft Guidance on Shortage Reporting During PHEs is ‘Too Broad’ and ‘Burdensome’
AdvaMed Tells FDA That Draft Guidance on Shortage Reporting During PHEs is ‘Too Broad’ and ‘Burdensome’
The medical device industry finds the FDA’s draft guidance on reporting medical device and diagnostic shortages during public health emergencies (PHEs) too far-reaching and too burdensome.